Yu-shih Lin
Jiayi Shi, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Glycyrrhiza glabra-Based Nasal Spray as a Novel Treatment for Chronic Rhinosinusitis with Nasal Polyps: Efficacy in Symptom Reduction and Epithelial-Mesenchymal Transition Modulation.
Journal: International journal of medical sciences
Published: August 07, 2025
Efficacy and immunomodulatory effects of licorice nasal spray in allergic rhinitis: A clinical study comparing with conventional steroid treatment.
Journal: Explore (New York, N.Y.)
Published: August 06, 2025
Antrodia cinnamomea Formula Suppresses Prostate Cancer Progression via Immune Modulation and PD-1/PD-L1 Pathway Inhibition.
Journal: International journal of molecular sciences
Published: January 02, 2025
The Inhibiting Effect of GB-2, (+)-Catechin, Theaflavin, and Theaflavin 3-Gallate on Interaction between ACE2 and SARS-CoV-2 EG.5.1 and HV.1 Variants.
Journal: International journal of molecular sciences
Published: July 11, 2024
Astragalus Polysaccharides and Metformin May Have Synergistic Effects on the Apoptosis and Ferroptosis of Lung Adenocarcinoma A549 Cells.
Journal: Current issues in molecular biology
Published: May 18, 2024
Inhibition of orthotopic castration-resistant prostate cancer growth and metastasis in mice by JC VLPs carrying a suicide gene driven by the PSA promoter.
Journal: Cancer gene therapy
Published: July 09, 2023
Induction of ferroptosis and apoptosis in endometrial cancer cells by dihydroisotanshinone I.
Journal: Heliyon
Published: June 28, 2023
The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution.
Journal: Heliyon
Published: January 17, 2023
Nasal irrigation with licorice extract (Glycyrrhiza glabra) in treating nasal polyps by reducing fibroblast differentiation and extracellular matrix production in TGF-β1-stimulated nasal polyp-derived fibroblasts by inhibiting the MAPK/ERK-1/2 pathway - an in vitro and in clinic study.
Journal: BMC complementary medicine and therapies
Published: August 17, 2022
Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 25, 2022
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 15, 2021
Last Updated: 09/26/2026